T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

NCT00242515 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National University Hospital, Singapore

Collaborators